United Capital Financial Advisers, LLC Bio Rad Laboratories, Inc. Transaction History

United Capital Financial Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $186,723 - $216,121	614 New	614 $212,000
Q1 2023 Aug 14, 2023	BUY	$418.69 - $503.0 $175,431 - $210,757	419 New	419 $200,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $175,431 - $210,757	419 New	419 $200,000
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $13,428 - $15,716	-42 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $12,791 - $14,500	42 New	42 $14,000
Q1 2019 May 14, 2019	SELL	$224.3 - $317.41 $276,113 - $390,731	-1,231 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $270,943 - $380,379	1,231 New	1,231 $286,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.